Selected article for: "cell proliferation and Plau gene"

Author: Ali Gibran; Runzhen Zhao; Mo Zhang; Krishan G. Jain; Jianjun Chang; Satoshi Komatsu; Xiaohui Fang; Beiyun Zhou; Jiurong Liang; Dianhua Jiang; Mistuo Ikebe; Michael A Matthay; Hong-Long Ji
Title: Fibrinolytic niche is requested for alveolar type 2 cell-mediated alveologenesis and injury repair
  • Document date: 2020_3_25
  • ID: 4h930ksd_19
    Snippet: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.24.006270 doi: bioRxiv preprint of injured muscle is improved by knocking out the Serpine1 gene142. The Plau gene regulates the proliferation of various cells, including renal epithelial cells43 , 44, umbilical vein endothelial cells45, vascular endothelial cells46, and keratinocytes47 , 48. Contrary to this, Serpine1 is a negative regula.....
    Document: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.24.006270 doi: bioRxiv preprint of injured muscle is improved by knocking out the Serpine1 gene142. The Plau gene regulates the proliferation of various cells, including renal epithelial cells43 , 44, umbilical vein endothelial cells45, vascular endothelial cells46, and keratinocytes47 , 48. Contrary to this, Serpine1 is a negative regulator of cell proliferation through the phosphatidylinositol3-kinase/Akt pathway in endothelial cells49 , 50. Our study uncovers a new signaling pathway of the fibrinolytic niche in the AT2 cell-mediated re-alveolarization. The uPA/A6/CD44 /ENaC cascade is involved in the regulation of self-renewal and differentiation of mouse and human AT2 cells, particularly the CD44 + subpopulation. This conclusion was further substantiated in Serpine1 Tg mice that have a disrupted fibrinolytic niche similar to the Plau -/mice, and both mouse lines are reasonable pre-clinical models of ARDS.

    Search related documents:
    Co phrase search for related documents
    • Akt pathway and cell proliferation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • Akt pathway and mouse line: 1
    • Akt pathway and negative regulator: 1, 2, 3
    • Akt pathway and self renewal: 1
    • Akt pathway and signaling pathway: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • Akt pathway and umbilical vein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • cell mediate and signaling pathway: 1, 2, 3, 4
    • cell proliferation and mouse line: 1, 2, 3, 4, 5, 6
    • cell proliferation and negative regulator: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • cell proliferation and Plau gene: 1
    • cell proliferation and self renewal: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • cell proliferation and signaling pathway: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cell proliferation and umbilical vein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • cell proliferation negative regulator and negative regulator: 1, 2
    • fibrinolytic niche and self renewal: 1
    • fibrinolytic niche and Serpine1 Tg mouse: 1
    • mouse line and negative regulator: 1
    • mouse line and signaling pathway: 1, 2, 3, 4
    • negative regulator and umbilical vein: 1